Kase Satoru, Kitaichi Nobuyoshi, Namba Kenichi, Miyazaki Akiko, Yoshida Kazuhiko, Ishikura Kenji, Ikeda Masahiro, Nakashima Taiji, Ohno Shigeaki
Department of Ophthalmology and Visual Sciences and Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Am J Kidney Dis. 2006 Dec;48(6):935-41. doi: 10.1053/j.ajkd.2006.09.013.
Tubulointerstitial nephritis and uveitis (TINU) syndrome is characterized by a combination of idiopathic acute tubulointerstitial nephritis and uveitis. Krebs von den Lunge-6 (KL-6) is a human glycoprotein secreted by type II alveolar cells in the lung, and its serum levels increase in patients with pneumonia of various causes, as well as ocular sarcoidosis. The aim of the present study is to quantify serum KL-6 levels in patients with TINU syndrome, which has no pulmonary and sarcoid lesions, and elucidate the usefulness of KL-6 for the diagnosis and follow-up of this syndrome.
Serum and urinary samples were obtained from 17 patients with TINU syndrome and 36 age-matched patients with uveitis from other causes. Sarcoidosis was eliminated because serum KL-6 levels increased during their lung lesion. Serum KL-6 level was determined by using a human KL-6 electrochemiluminescence immunoassay. Formalin-fixed paraffin-embedded renal tissue sections were incubated with anti-KL-6 monoclonal antibody, then examined immunohistochemically.
Mean serum KL-6 levels for patients with TINU syndrome and those with uveitis from other causes were 363.35 +/- 51.06 and 213.19 +/- 10.28 U/mL, respectively (P < 0.001). Urinary beta(2)-microglobulin levels of patients with TINU syndrome and uveitis from other causes were 4.06 +/- 1.31 and 0.16 +/- 0.20 mg/L, respectively (P < 0.001). All patients with TINU syndrome showed a simultaneous decrease in serum KL-6 and urinary beta(2)-microglobulin levels after the beginning of treatment. Strong immunoreactivity for KL-6 was observed in renal distal tubules in biopsy tissue of patients with TINU syndrome.
We show a significant increase in serum KL-6 levels in patients with TINU syndrome, whereas levels were normal in patients with other causes of uveitis without nephritis. Renal distal tubules stained strongly with anti-KL-6 antibody, suggesting that high KL-6 levels may reflect the renal lesion of TINU syndrome. Serum KL-6 may be a potential laboratory parameter for the diagnosis and follow-up of patients with TINU syndrome that could complement urinary beta(2)-microglobulin measurements.
肾小管间质性肾炎和葡萄膜炎(TINU)综合征的特征是特发性急性肾小管间质性肾炎和葡萄膜炎同时出现。克雷布斯-冯-登-龙格-6(KL-6)是一种由肺Ⅱ型肺泡细胞分泌的人糖蛋白,在各种原因引起的肺炎以及眼部结节病患者中,其血清水平会升高。本研究的目的是量化无肺部和结节病病变的TINU综合征患者的血清KL-6水平,并阐明KL-6在该综合征诊断和随访中的作用。
从17例TINU综合征患者和36例年龄匹配的其他原因引起的葡萄膜炎患者中获取血清和尿液样本。由于结节病患者肺部病变时血清KL-6水平会升高,故将其排除。采用人KL-6电化学发光免疫分析法测定血清KL-6水平。将福尔马林固定石蜡包埋的肾组织切片与抗KL-6单克隆抗体孵育,然后进行免疫组织化学检查。
TINU综合征患者和其他原因引起的葡萄膜炎患者的平均血清KL-6水平分别为363.35±51.06和213.19±10.28 U/mL(P<0.001)。TINU综合征患者和其他原因引起的葡萄膜炎患者的尿β2-微球蛋白水平分别为4.06±1.31和0.16±0.20 mg/L(P<0.001)。所有TINU综合征患者在治疗开始后血清KL-6和尿β2-微球蛋白水平同时下降。在TINU综合征患者的活检组织中,肾远曲小管观察到KL-6强免疫反应性。
我们发现TINU综合征患者血清KL-6水平显著升高,而其他无肾炎的葡萄膜炎病因患者的水平正常。肾远曲小管被抗KL-6抗体强烈染色,提示高KL-6水平可能反映TINU综合征的肾脏病变。血清KL-6可能是TINU综合征患者诊断和随访的潜在实验室参数,可补充尿β2-微球蛋白检测。